Mr Mark Macenka > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Mr Mark Macenka
Position
Partner
Career
Mark Macenka, a partner in Goodwin’s Corporate and Technology Companies groups, has over 28 years’ experience in the areas of business and securities law, mergers and acquisitions, venture capital and corporate finance. He joined the firm in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP.
Mr. Macenka represents public and private growth oriented companies in emerging and high technology industries, as well as venture capital firms and investment banks. His experience includes business counseling, domestic and international mergers and acquisitions, public and private financing, domestic and international software, Internet, telecommunications and technology licensing and distribution, and strategic partnerships and joint ventures. Mr. Macenka’s practice has included cross border financings and acquisitions, as well as advice on other U.S.-based activities for companies headquartered or with significant operations in Australia, Canada, France, Ireland, Israel, Lebanon and Russia.
Mr. Macenka also serves as chair of the Business Law Department, as co-chair of the firm’s Pro Bono Committee and a member of the Executive and Management Committees.
Education
J.D., 1983 Harvard Law School A.B., 1980 Georgetown University (magna cum laude)
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)